Differentiation-inducing factor-1, a morphogen of dictyostelium, induces G(1) arrest and differentiation of vascular smooth muscle cells

Area of Science:

• Cell Biology
• Molecular Biology
• Cardiovascular Research

Background:

• Differentiation-inducing factor-1 (DIF-1) is a morphogen known to induce differentiation in Dictyostelium.
• Recent studies suggest DIF-1 inhibits tumor cell proliferation and induces differentiation, but mechanisms are unclear.
• Vascular smooth muscle cell (VSMC) proliferation and dedifferentiation contribute to atherosclerosis.

Purpose of the Study:

• To investigate the effects of DIF-1 on VSMC proliferation and differentiation.
• To explore DIF-1 as a potential therapeutic agent for atherosclerosis.

Main Methods:

• Assessed DNA synthesis and cell division in mitogen-stimulated VSMCs treated with DIF-1.
• Analyzed retinoblastoma protein phosphorylation and cyclin-dependent kinase (Cdk) activities (Cdk4, Cdk6, Cdk2).
• Quantified expression levels of cyclins (D1, D2, D3, E, A) and smooth muscle myosin heavy chains (SM1, SM2, SMemb) via mRNA analysis.

Main Results:

• DIF-1 significantly inhibited DNA synthesis and cell division in VSMCs.
• DIF-1 suppressed retinoblastoma protein phosphorylation and Cdk activities.
• DIF-1 downregulated D-type cyclins (D1, D2, D3) and cyclins E and A, likely arresting cells in early G1 phase.
• DIF-1 prevented the decrease of SM1 and SM2 mRNA in quiescent cells and induced their expression in dedifferentiated cells, while reducing SMemb.

Conclusions:

• DIF-1 inhibits VSMC proliferation by suppressing D-type cyclin expression and arresting cells in early G1 phase.
• DIF-1 promotes VSMC differentiation, indicated by SM1/SM2 induction and SMemb reduction.
• DIF-1 demonstrates potential for preventing phenotypic modulation and inducing differentiation in VSMCs, suggesting therapeutic applications for atherosclerosis.